Metformin
HCl
To guarantee the highest purity and efficacy, we adhere to strict global standards
To guarantee the highest purity and efficacy, we adhere to strict global standards
Metformin Hydrochloride is the First-line Active Pharmaceutical Ingredient (API) for the treatment of Type 2 Diabetes Mellitus. It belongs to the Biguanides class. It is highly valued for its efficacy in improving insulin sensitivity without causing weight gain or severe hypoglycemia. We supply Metformin HCl as a white crystalline powder, suitable for manufacturing both immediate-release and extended-release tablets.
Standard tablets taken two or three times daily.
High powder quality ensures rapid dissolution and good bioavailability.
Controlled/Sustained Release tablets for once-daily dosing.
API powder supplied with uniform flow and compressibility characteristics, essential for granulation and compression processes used in ER formulations.
Tablets combining Metformin with other antidiabetic drugs (e.g., DPP-4 inhibitors).
Excellent compatibility with a wide range of excipients and other APIs in co-formulated tablets.
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).